Scaled-down doses for perioral treatment than for higher facial purposes are employed since the oral musculature responds a lot more strongly to precisely the same BTX-A dosing. Only one preparation of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indication and FDA acceptance lies in treatments of cervical dystonia. https://eminemi158fmu2.ttblogs.com/profile